ZTrials

Updates to guidances:

ICH Official web site : ICH

ORILISSA is a GnRH receptor antagonist.

ORILISSA® (elagolix) 150 mg or 200 mg Tablets | Official HCP Site The official ORILISSA® (elagolix) health care professional site from AbbVie Inc. Learn about the use, benefits, side effects, and risks of ORILISSA 150 mg or 200 mg tablets.

Progress Report highlights the following:
1. Accomplishments of the BMT CTN, including a detailed report of the Network’s activities for the period of May 1, 2018, through April 30, 2019, (highlights bolded throughout the report) as well as plans for the upcoming year;
2. Organizational structure of the Network;
3. Structure, responsibilities, and focus of the Network’s Data and Coordinating Center (DCC);
4. Network collaborations;
5. Protocol selection, development, and management processes;
6. Past and current protocol status updates

web.emmes.com